The increasing field of immunotherapy relies heavily on recombinant cytokine Recombinant Human β-NGF technology, and a precise understanding of individual profiles is absolutely crucial for fine-tuning experimental design and therapeutic efficacy. Specifically, examining the properties of recombinant IL-1A, IL-1B, IL-2, and IL-3 demonstrates signi